Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
VAD
Description:
An abbreviation apparently associated with Vadsø and nearby localities in Norwegian geographical and municipal contexts.
Related topics:
Multiple Myeloma Research and Treatments (16%),
Photographic and Visual Arts (12%)
OpenAlex ID:
keywords/vads
Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial
2012
·
Pieter Sonneveld
, Ingo G.H. Schmidt-Wolf
, et al.
·
Journal of Clinical Oncology
·
877
Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
2000
·
Hagop M. Kantarjian
, Susan O’Brien
, et al.
·
Journal of Clinical Oncology
·
833
Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials
2013
·
Pieter Sonneveld
, Hartmut Goldschmidt
, et al.
·
Journal of Clinical Oncology
·
267
PDF
Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma
2006
·
T. Facon
, J. Mary
, et al.
·
Journal of Clinical Oncology
·
196
Higher Infused Lymphocyte Dose Predicts Higher Lymphocyte Recovery, Which in Turn, Predicts Superior Overall Survival following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
2007
·
Devendra K. Hiwase
, Smita Hiwase
, et al.
·
Transplantation and Cellular Therapy
·
96
PDF
The Treatment of Multiple Myeloma
1948
·
J F San Miguel
, J Bladé Creixenti
, et al.
·
The Medical Journal of Australia
·
86
Bortezomib/dexamethasone versus VAD as induction prior to autologous stem cell transplantion (ASCT) in previously untreated multiple myeloma (MM): Updated data from IFM 2005/01 trial
2008
·
J. L. Harousseau
, C. Mathiot
, et al.
·
Journal of Clinical Oncology
·
83
Major Superiority of Melphalan - Prednisone (MP) + Thalidomide (THAL) over MP and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients with Multiple Myeloma.
2005
·
Thierry Facon
, J.Y. Mary
, et al.
·
Blood
·
66
Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53
2006
·
Jinzhao Wang
, Navjotsingh Pabla
, et al.
·
American Journal of Physiology-Renal Physiology
·
60
A Multimodal Dataset for Mixed Emotion Recognition
2024
·
Pei Yang
, Niqi Liu
, et al.
·
Scientific Data
·
56
First World War Nursing: New Perspectives
2013
·
Routledge eBooks
·
46
DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma
2001
·
M Lazzarino
, A Corso
, et al.
·
Bone Marrow Transplantation
·
43
Challenging Discourses on Rurality: Women and Men In-migrants' Constructions of the Good Life in a Rural Town in Northern Norway
2006
·
Mai Camilla Munkejord
·
Sociologia Ruralis
·
40
Bortezomib Induction and Maintenance in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-up of the HOVON-65/GMMG-HD4 Trial
2015
·
Pieter Sonneveld
, Hans-Juergen Salwender
, et al.
·
Blood
·
39
Técnicas para evaluar la memoria del niño
2003
·
Ana María Soprano
·
Revista de Neurología
·
30
Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial
2013
·
Pieter Sonneveld
, Christof Scheid
, et al.
·
Blood
·
26
Intensive Versus Double Intensive Therapy in Untreated Multiple Myeloma: Updated Analysis of the Randomized Phase III Study HOVON 24 MM.
2004
·
Pieter Sonneveld
, Bronno van der Holt
, et al.
·
Blood
·
19
Post‐transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high‐dose melphalan with autologous stem cell support
2007
·
Dan T. Vogl
, Stephen V. Liu
, et al.
·
American Journal of Hematology
·
16
PDF
A Phase I–II Trial of Bortezomib (Velcade) (Vc) and Oral Cyclophosphamide (CY) Plus Prednisone (P) for Relapsed/Refractory Multiple Myeloma (MM).
2005
·
Donna E. Reece
, Giovanni Piza
, et al.
·
Blood
·
14
Medical adhesive-related skin injury: VADS and dressings
2015
·
Jan Hitchcock
, Louise Savine
·
British Journal of Nursing
·
13
Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies
2012
·
Michele Cavo
, Pieter Sonneveld
, et al.
·
Blood
·
12
Religion og fiendbilder : læstadianismen, statskirken og kvenene 1870-1940.
2013
·
Rolf Inge Larsen
·
NORA - Norwegian Open Research Archives
·
10
Induction with Velcade®/Dexamethasone Partially Overcomes the Poor Prognosis of t(4;14), but Not That of Del(17p), in Young Patients with Multiple Myeloma.
2009
·
Hervé Avet Loiseau
, Philippe Moreau
, et al.
·
Blood
·
10
SK-RD4AD: Skip-Connected Reverse Distillation for Robust One-Class Anomaly Detection
2025
·
Eunju Park
, Taekyung Kim
, et al.
·
IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW)
·
9
Bortezomib (BOR) and High Dose Melphalan (HDM) as Conditioning Regimen Before Autologous Stem Cell Transplantation (ASCT) for De Novo Multiple Myeloma (MM): Final Results of the IFM Phase II Study VEL/MEL
2008
·
Murielle Roussel
, Anne Huynh
, et al.
·
Blood
·
9
Show more works
View as search
Works count:
303
Citation count:
3,080
Year
Topic
Type